Trials / Completed
CompletedNCT02957851
EMONO for the Treatment of Peripheral Neuropathic Pain
Equimolar Mixture of Oxygen and Nitrous Oxide (EMONO) for the Treatment of Peripheral Neuropathic Pain: A Randomises, International, Multicentre, Placebo-Controlled, Phenotype-stratified Phase IIa Study
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 287 (actual)
- Sponsor
- Air Liquide Santé International · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
To assess the effect of 3 consecutive days of one-hour administration of Nitrous Oxide/Oxygen 50%/50% (EMONO) versus placebo as Oxygen/Nitrogen 22%/78% (synthetic medical air), in add-on therapy to chronic analgesic treatments, on average pain intensity in patients with chronic peripheral neuropathic pain. A total of 250 randomised patients to be included in all the participating centres, i.e., 125 randomised patients in each of the 2 study groups treatments
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Medical Air | |
| DRUG | EMONO |
Timeline
- Start date
- 2016-11-01
- Primary completion
- 2018-08-01
- Completion
- 2018-08-01
- First posted
- 2016-11-08
- Last updated
- 2018-09-21
Locations
22 sites across 2 countries: France, Germany
Source: ClinicalTrials.gov record NCT02957851. Inclusion in this directory is not an endorsement.